Revvity Inc
RVTY96.200USD
-0.060-0.06%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
10.97BCap. mercado
48.35P/E TTM
Más Datos de Revvity Inc Compañía
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Información de Revvity Inc
Símbolo de cotizaciónRVTY
Nombre de la empresaRevvity Inc
Fecha de salida a bolsaAug 12, 2101
Director ejecutivoSingh (Prahlad R)
Número de empleados11000
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 12
Dirección77 4Th Avenue
CiudadWALTHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02451
Teléfono17816636900
Sitio Webhttps://www.revvity.com/
Símbolo de cotizaciónRVTY
Fecha de salida a bolsaAug 12, 2101
Director ejecutivoSingh (Prahlad R)
Ejecutivos de Revvity Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+21.36%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
10.44K
-53.85%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+90.13%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+90.13%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Product
610.70M
84.79%
Service
109.58M
15.21%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
323.58M
44.92%
Europe
203.63M
28.27%
Asia
193.07M
26.80%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product
610.70M
84.79%
Service
109.58M
15.21%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Otro
46.93%
Accionistas
Accionistas
Proporción
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Otro
46.93%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
70.04%
Investment Advisor/Hedge Fund
25.98%
Hedge Fund
2.79%
Pension Fund
1.77%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
1.07%
Individual Investor
0.30%
Family Office
0.05%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
T. Rowe Price Investment Management, Inc.
22.64M
19.51%
+126.19K
+0.56%
Jun 30, 2025
The Vanguard Group, Inc.
14.03M
12.09%
-297.65K
-2.08%
Jun 30, 2025
EdgePoint Investment Group Inc.
6.79M
5.85%
+1.43M
+26.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.80M
6.72%
-1.59M
-16.90%
Jun 30, 2025
Janus Henderson Investors
7.22M
6.22%
+1.23M
+20.47%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.81M
5%
-259.62K
-4.28%
Jun 30, 2025
State Street Investment Management (US)
5.02M
4.32%
-150.58K
-2.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.98M
2.56%
-18.52K
-0.62%
Jun 30, 2025
Invesco Capital Management LLC
1.94M
1.67%
+422.41K
+27.88%
Jun 30, 2025
UBS Financial Services, Inc.
1.75M
1.51%
+1.12M
+178.25%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
Ver más
First Trust Indxx Medical Devices ETF
Proporción2.12%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.85%
T Rowe Price Capital Appreciation Equity ETF
Proporción1.36%
Simplify Health Care ETF
Proporción1.29%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.16%
First Trust Health Care Alphadex Fund
Proporción0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proporción0.84%
VanEck Morningstar SMID Moat ETF
Proporción0.64%
Neuberger Berman Small-Mid Cap ETF
Proporción0.56%
NYLI Candriam US Mid Cap Equity ETF
Proporción0.5%
Dividendos
Un total de
168.35M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Revvity Inc?
Los cinco principales accionistas de Revvity Inc son:
T. Rowe Price Investment Management, Inc. posee 22.64M acciones, lo que representa el 19.51% del total de acciones.
The Vanguard Group, Inc. posee 14.03M acciones, lo que representa el 12.09% del total de acciones.
EdgePoint Investment Group Inc. posee 6.79M acciones, lo que representa el 5.85% del total de acciones.
T. Rowe Price Associates, Inc. posee 7.80M acciones, lo que representa el 6.72% del total de acciones.
Janus Henderson Investors posee 7.22M acciones, lo que representa el 6.22% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 22.64M acciones, lo que representa el 19.51% del total de acciones.
The Vanguard Group, Inc. posee 14.03M acciones, lo que representa el 12.09% del total de acciones.
EdgePoint Investment Group Inc. posee 6.79M acciones, lo que representa el 5.85% del total de acciones.
T. Rowe Price Associates, Inc. posee 7.80M acciones, lo que representa el 6.72% del total de acciones.
Janus Henderson Investors posee 7.22M acciones, lo que representa el 6.22% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Revvity Inc?
Los tres principales tipos de accionista de Revvity Inc son:
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
¿Cuántas instituciones poseen acciones de Revvity Inc (RVTY)?
A fecha de 2025Q3, 1177 instituciones poseen acciones de Revvity Inc, con un valor de mercado combinado de aproximadamente 117.06M, lo que representa el 100.85% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 2.82%.
¿Cuál es la mayor fuente de ganancias de Revvity Inc?
El FY2025Q2, el segmento empresarial Product generó la ganancia más alta para Revvity Inc, ascendiendo a 610.70M y representando el 84.79% de la ganancia total.
